Verheugen Outlines New Pharmaceutical Strategy
The European pharmaceutical sector, once the bastion of pharmaceutical innovation, is falling behind the United States in terms of innovation and R&D (research & development) expenditure and is increasingly under threat from newcomers, especially in India and China. Today, in a speech at the European Federation of Pharmaceutical Industries and Association (EFPIA), Commission Vice-President Günter Verheugen has addressed these difficulties and outlined elements of a new Commission industrial strategy for the pharmaceutical sector that goes beyond regulatory interventions by enhancing the environment for innovation and investment, reflecting on ways to give more market flexibility to industry and improving quality of information to patients and patient safety. For more info, also see MEMO/05/186 and SPEECH/05/311.
Read more here.
News Source: Cordis